Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies.
about
Timing of therapies for Down syndrome: the sooner, the betterPharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoringUse of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and SwedenSelective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.CALM Pregnancy: results of a pilot study of mindfulness-based cognitive therapy for perinatal anxiety.Antidepressant use in pregnant and postpartum womenEarly-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats.Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis.Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.Prenatal depression and adverse birth outcomes: an updated systematic review.Human milk for the premature infant.The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspringOf rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.The use of central nervous system active drugs during pregnancy.Effects of maternal psychotropic drug dosage on birth outcomes.The effect of regulatory advisories on maternal antidepressant prescribing, 1995-2007: an interrupted time series study of 228,876 pregnancies.Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy.The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies.A rock and a hard place: The selective serotonin reuptake inhibitor dilemmas in addressing perinatal mood and anxiety disorders.Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making.Development of a mother-child database for drug exposure and adverse event detection in the Military Health System.Nitrosatable Drug Exposure during Pregnancy and Preterm and Small-for-Gestational-Age Births.Obstetric outcomes in pregnant women with and without depression: population-based comparison.Perinatal citalopram does not prevent the effect of prenatal stress on anxiety, depressive-like behaviour and serotonergic transmission in adult rat offspring.Longitudinal trajectories of antidepressant use in pregnancy and the postnatal period.Impact of antidepressant treatment during pregnancy on obstetric outcomes among women previously treated for depression: an observational cohort study.Adverse obstetric outcomes during delivery hospitalizations complicated by suicidal behavior among US pregnant women.
P2860
Q26779297-1CB2F241-1B28-4447-9D6B-2736317B5784Q27027293-3D41A023-E267-4F17-8C79-D44E54C6F2C6Q28551620-09DC0DEA-7BE4-4CF3-9A38-68A76807DA4EQ30244451-91A74A46-3795-4BF6-A090-E9DA6D7EA588Q33935101-BD240D60-30C6-4570-A009-ADFF2B7BACA1Q34068023-D2905DFE-D019-4C66-AD43-03AA62C69B3BQ34714284-CDE4CA82-EE64-4B68-9B65-D9620F89A876Q35132422-B939CA5C-F944-478A-8A06-9222B8F62F29Q35541040-A0F1688C-A04C-4749-A208-7EF09A6540D8Q35661005-A87EA7A6-D1F2-4181-AC64-2689FB913448Q36429371-F062442A-0AC7-446E-8722-EE8D51DE713FQ36860205-EA6203A3-1B72-43D0-9417-98A5A6495B8AQ37058701-78DD33CE-E131-47D4-880A-2BFFA14C3A7AQ37280003-A7BCEB3D-5782-4D2F-8FD7-047D1807F2A9Q37397151-F62CAF7F-BCBE-4C08-A642-5D1A3BC90B42Q37606641-15398D64-399F-4A67-BF9A-05CAE1BB4147Q38089714-08473BFD-F0E0-48FE-AB88-8A8A78F33783Q38672603-0CAA902C-69CF-4F83-B603-EBA422110D25Q38784504-4511C428-2D6A-4FF4-BDF9-315278DE90CFQ38811512-767A91E8-108D-4A02-B58D-0E37E7A6EB47Q41125596-783602E0-B070-41F7-A6C7-2512B12F463AQ41708862-68B3E23A-B4F3-4CEB-A3CD-E00E96495AA6Q42638323-A958CEAD-C57C-4267-9EEB-025AFBF44A82Q47608827-E8436E55-A788-45F4-86F7-D810F37F98F6Q47653799-E88BE271-8F53-415E-B44A-4C6AFF99DB90Q47835376-9CD30C4A-1016-477E-BF7D-13F229170D3CQ49979649-F7D461D9-83E5-4D19-8B47-59088AAE183E
P2860
Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies.
@ast
Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies.
@en
type
label
Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies.
@ast
Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies.
@en
prefLabel
Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies.
@ast
Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies.
@en
P2093
P2860
P1476
Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies.
@en
P2093
Ed Mitchel
Pingsheng Wu
Rachel M Hayes
Richard C Shelton
Tina V Hartert
William O Cooper
P2860
P304
P356
10.1016/J.AJOG.2012.04.028
P407
P577
2012-04-30T00:00:00Z